Ac-SDKP peptide improves functional recovery following spinal cord injury in a preclinical model. 2022

Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Damage to the spinal cord triggers a local complex inflammatory reaction that results in irreversible impairments or complete loss of motor function. The evidence suggested that inhibiting the pro-inflammatory macrophage/microglia (M1 subsets) and stimulating the anti-inflammatory macrophage/microglia (M2 subsets) are potential strategies for the treatment of neuroinflammation-related diseases. We evaluated the potentially protective effect of Ac-SDKP as an endogenous tetrapeptide on rat spinal cord injury (SCI). Wistar rats were subjected to a weight-drop contusion model and were treated with Ac-SDKP (0.8 mg/kg) given subcutaneously once a day for 7 days starting at two clinically relevant times, at 2 h or 6 h post-injury. The effect of Ac-SDKP was assessed by motor functional analysis, real-time PCR (CD86 and CD206 mRNA), western blot (caspase-3), ELISA (TNF-a, IL-10), and histological analysis (toluidine blue staining). Ac-SDKP improved locomotor recovery and rescue motor neuron loss after SCI. Moreover, a decreased in TNF-a level as well as caspase 3 protein levels occurred in the lesion epicenter of the spinal cord following treatment. In addition, CD206 mRNA expression level increased significantly in Ac-SDKP treated rats compared with SCI. Together these data suggest that Ac-SDKP might be a novel immunomodulatory drug. It may be beneficial for the treatment of SCI with regards to increasing CD206 gene expression and suppress inflammatory cytokine to improve motor function and reducing histopathological lesion.

UI MeSH Term Description Entries
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013116 Spinal Cord A cylindrical column of tissue that lies within the vertebral canal. It is composed of WHITE MATTER and GRAY MATTER. Coccygeal Cord,Conus Medullaris,Conus Terminalis,Lumbar Cord,Medulla Spinalis,Myelon,Sacral Cord,Thoracic Cord,Coccygeal Cords,Conus Medullari,Conus Terminali,Cord, Coccygeal,Cord, Lumbar,Cord, Sacral,Cord, Spinal,Cord, Thoracic,Cords, Coccygeal,Cords, Lumbar,Cords, Sacral,Cords, Spinal,Cords, Thoracic,Lumbar Cords,Medulla Spinali,Medullari, Conus,Medullaris, Conus,Myelons,Sacral Cords,Spinal Cords,Spinali, Medulla,Spinalis, Medulla,Terminali, Conus,Terminalis, Conus,Thoracic Cords
D013119 Spinal Cord Injuries Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.). Myelopathy, Traumatic,Injuries, Spinal Cord,Post-Traumatic Myelopathy,Spinal Cord Contusion,Spinal Cord Laceration,Spinal Cord Transection,Spinal Cord Trauma,Contusion, Spinal Cord,Contusions, Spinal Cord,Cord Contusion, Spinal,Cord Contusions, Spinal,Cord Injuries, Spinal,Cord Injury, Spinal,Cord Laceration, Spinal,Cord Lacerations, Spinal,Cord Transection, Spinal,Cord Transections, Spinal,Cord Trauma, Spinal,Cord Traumas, Spinal,Injury, Spinal Cord,Laceration, Spinal Cord,Lacerations, Spinal Cord,Myelopathies, Post-Traumatic,Myelopathies, Traumatic,Myelopathy, Post-Traumatic,Post Traumatic Myelopathy,Post-Traumatic Myelopathies,Spinal Cord Contusions,Spinal Cord Injury,Spinal Cord Lacerations,Spinal Cord Transections,Spinal Cord Traumas,Transection, Spinal Cord,Transections, Spinal Cord,Trauma, Spinal Cord,Traumas, Spinal Cord,Traumatic Myelopathies,Traumatic Myelopathy
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D020127 Recovery of Function A partial or complete return to the normal or proper physiologic activity of an organ or part following disease or trauma. Function Recoveries,Function Recovery

Related Publications

Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
May 2014, Molecular medicine reports,
Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
January 2014, Neuroscience,
Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
February 2011, Brain research,
Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
September 2008, Experimental neurology,
Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
July 2021, Cell reports,
Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
September 2009, Experimental neurology,
Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
December 2019, Brain research,
Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
June 2003, Journal of neurotrauma,
Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
July 2020, Biomedicines,
Shiva Hashemizadeh, and Soheila Pourkhodadad, and Saereh Hosseindoost, and Sina Pejman, and Maryam Kamarehei, and Abolfazl Badripour, and Ameneh Omidi, and Seyed Khalil Pestehei, and Alexander M Seifalian, and Mahmoudreza Hadjighassem
February 2023, EMBO molecular medicine,
Copied contents to your clipboard!